InvestorsHub Logo

toohot

07/30/22 7:45 PM

#295077 RE: Craig305 #295059

LOL HERE YA GO from the undisputed truth:

What is false?
That they did not enter the challenge?
How can there be links to something that did not happen?



BioElectronics Applies for FDA’s Opioid Alternative Innovation Challenge Program
AUGUST 13, 2018 NEWS, PRESS RELEASES

IANWAR@BIELCORP.COM
FREDERICK, MD, Aug. 13, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com, is pleased to announce that it has submitted an application to the U.S. Food and Drug Administration’s 2018 Opioid Innovation Challenge. This challenge was designed by the FDA to spur the development/deployment of medical devices that can help combat the opioid crisis by preventing/treating opioid use disorder. Click for FDA Challenge Website.

There are more than 245 million opioid prescriptions written annually in the US. BioElectronics’ products are FDA-cleared, nonprescription neuromodulation medical devices that provide pain therapy as an alternative to opioid medications.

BUY $BIEL